Skip to main content

Table 1 Demographic and clinical characteristics

From: Augmented efficacy of intermittent theta burst stimulation on the virtual reality-based cycling training for upper limb function in patients with stroke: a double-blinded, randomized controlled trial

 

sham iTBS + VCT

iTBS + VCT

p-value

Age

48.95 ± 9.63

54.36 ± 10.56

0.316a

Gender

  

0.317b

 Male

10 (90.9%)

8 (66.7%)

 

 Female

1 (9.1%)

4 (33.3%)

 

Onset time (month)

7.99 ± 5.41

5.01 ± 4.39

0.449a

Stroke type

  

0.193b

 Infarction

2 (18.2%)

6 (50.0%)

 

 Hemorrhage

9 (81.8%)

6 (50.0%)

 

Stroke side

  

1.000b

 Right

4 (36.4%)

5 (41.7%)

 

 Left

7 (63.6%)

7 (58.3%)

 

Stroke location

  

1.000b

 Cortical

2 (18.2%)

3 (25.0%)

 

 M1 involvement

2 (18.2%)

2 (16.7%)

 

 Subcortical

9 (81.8%)

9 (75.0%)

 

MEP

  

0.879b

 Positive

7 (63.6%)

8 (66.7%)

 

 Negative

4 (36.4%)

4 (33.3%)

 

Aphasia

  

0.640b

 Yes

3 (27.3%)

2 (16.7%)

 

 No

8 (72.7%)

10 (83.3%)

 

NIHSS

13.55 ± 2.38

11.92 ± 1.73

0.190a

  1. Data are presented as mean ± standard deviation or number (%)
  2. iTBS intermittent theta burst stimulation, MCA middle cerebral artery, MEP motor evoked potential, NIHSS National Institutes of Health Stroke Scale
  3. aMann-Whitney U tests
  4. bChi-square tests